BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules

POMPANO BEACH, Fla., Sept. 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. NASDAQ:BSEM (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that it has en…